Direkt zum Inhalt
Merck
  • Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

Gut (2014-06-28)
Parambir S Dulai, Corey A Siegel, Jean-Frederic Colombel, William J Sandborn, Laurent Peyrin-Biroulet
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
6-Mercaptopurin Monohydrat, 98%
Sigma-Aldrich
Azathioprin, ≥98%
Supelco
Azathioprin, Pharmaceutical Secondary Standard; Certified Reference Material
Azathioprin, European Pharmacopoeia (EP) Reference Standard